These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 25185620

  • 1. Rare case of neglected pessary presenting with concealed vaginal hemorrhage.
    Andrikopoulou M, Lazarou G.
    Female Pelvic Med Reconstr Surg; 2015; 21(1):e1-2. PubMed ID: 25185620
    [Abstract] [Full Text] [Related]

  • 2. An Arterial Vaginal Bleed Resulting from Short-Term Pessary Use: A Case Report.
    Rieben K, Epp A.
    J Obstet Gynaecol Can; 2021 Apr; 43(4):503-505. PubMed ID: 33153940
    [Abstract] [Full Text] [Related]

  • 3. Does vaginal estrogen treatment with support pessaries in vaginal prolapse reduce complications?
    Bulchandani S, Toozs-Hobson P, Verghese T, Latthe P.
    Post Reprod Health; 2015 Dec; 21(4):141-5. PubMed ID: 26537626
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Vaginal evisceration during pessary fitting and treatment with immediate colpocleisis.
    Rubin R, Jones KA, Harmanli OH.
    Obstet Gynecol; 2010 Aug; 116 Suppl 2():496-498. PubMed ID: 20664431
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Management of incarcerated vaginal pessaries.
    Poma PA.
    J Am Geriatr Soc; 1981 Jul; 29(7):325-7. PubMed ID: 7240622
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of vaginal estrogen on pessary use.
    Dessie SG, Armstrong K, Modest AM, Hacker MR, Hota LS.
    Int Urogynecol J; 2016 Sep; 27(9):1423-9. PubMed ID: 26992727
    [Abstract] [Full Text] [Related]

  • 12. [Complications related to pessary use in the treatment of female pelvic organ prolapse].
    Mooij R, Potijk TM, Schrickx JA.
    Ned Tijdschr Geneeskd; 2021 Jul 22; 165():. PubMed ID: 34346635
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Discontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse.
    Yimphong T, Temtanakitpaisan T, Buppasiri P, Chongsomchai C, Kanchaiyaphum S.
    Int Urogynecol J; 2018 Aug 22; 29(8):1123-1128. PubMed ID: 28815277
    [Abstract] [Full Text] [Related]

  • 18. A 5-year prospective study of vaginal pessary use for pelvic organ prolapse.
    Lone F, Thakar R, Sultan AH, Karamalis G.
    Int J Gynaecol Obstet; 2011 Jul 22; 114(1):56-9. PubMed ID: 21575953
    [Abstract] [Full Text] [Related]

  • 19. Predictors for dislodgment of vaginal pessary within one year in women with pelvic organ prolapse.
    Cheung RYK, Lee LLL, Chung TKH, Chan SSC.
    Maturitas; 2018 Feb 22; 108():53-57. PubMed ID: 29290215
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.